Vernalis Plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vernalis Plc with three other
companies in this sector in the United Kingdom:
GW Pharmaceuticals PLC
sales of £10.32 million [US$13.28 million]
of which 63%
Midatech Pharma PLC
(£6.92 million [US$8.91 million]
of which 81%
was Commercial), and
(£9.13 million [US$11.75 million]
of which 100%
was Medical Service).